Compass Therapeutics (CMPX) Cash from Investing Activities (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Compass Therapeutics | 418.47 Mn | 223.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,237.63% |
| Dec 31, 2025 | 96.45% |
| Sep 30, 2025 | -1,396.16% |
| Jun 30, 2025 | -154.88% |
| Mar 31, 2025 | -24.61% |
| Dec 31, 2024 | -47.03% |
| Sep 30, 2024 | 347.60% |
| Jun 30, 2024 | 258.16% |
| Mar 31, 2024 | -164.92% |
| Dec 31, 2023 | -62.97% |
| Sep 30, 2023 | 2,656.07% |
| Jun 30, 2023 | -115.62% |
| Mar 31, 2023 | 109.15% |
| Dec 31, 2022 | -4,053.05% |
| Sep 30, 2022 | 101.12% |
| Jun 30, 2022 | -54,584.46% |
| Mar 31, 2022 | 75.13% |
| Dec 31, 2021 | -111.44% |
| Sep 30, 2021 | 40.23% |
| Jun 20, 2021 | -4,623.08% |
| Sep 30, 2020 | -17.95% |
| Jun 30, 2020 | 425.00% |
| Sep 30, 2019 | -10.63% |